Filter
139
Filtered Results: 139
Text search:
Novartis
Featured
Recommendations
11
New Publications
23
Language
Document type
No document type
65
Studies & Reports
47
Guidelines
14
Strategic & Response Plan
7
Situation Updates
2
Fact sheets
2
Manuals
1
Resource Platforms
1
Countries / Regions
Global
10
Africa
6
South Africa
6
Tanzania
5
India
4
Russia
3
Indonesia
3
Ukraine
2
Ghana
2
Nigeria
2
Philippines
2
Latin America and the Carribbean
2
Germany
2
Western and Central Europe
2
Nepal
1
Kenya
1
Sierra Leone
1
Chile
1
Malawi
1
Mozambique
1
Cambodia
1
Asia
1
Venezuela
1
Bangladesh
1
Brazil
1
Namibia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Countries
35
Public Health
15
Clinical Guidelines
8
Pharmacy & Technologies
6
Women & Child Health
1
Key Resources
1
Toolboxes
Mental Health
27
NCDs
24
NTDs
21
COVID-19
7
TB
6
Pharmacy
6
AMR
5
Disability
4
Planetary Health
4
Global Health Education
3
Rapid Response
2
HIV
2
Ebola & Marburg
2
Caregiver
2
Refugee
1
Health Financing Toolbox
1
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b158 (Published 05 February 2009)
Cite this as: BMJ 2009;338:b158
Correspondence to: A Burns alistair.burns@manchester.ac.uk
WHO Technical Series 971
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
760 WEEKLY EPIDEMIOLOGICAL RECORD, NOS. 51/52, 20 DECEMBER 2024, pp.760-769. In French and English
BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is increasing in low- and middle-income countries and remains under-recognised and poorly managed.
OBJE...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
